Flt3 signaling-dependent dendritic cells protect against atherosclerosis

Immunity

Volumn 35, Issue 5, 2011, Pages 819-831

  Choi, Jae Hoon ^a,b   Cheong, Cheolho ^a   Dandamudi, Durga B ^a   Park, Chae Gyu ^a   Rodriguez, Anthony ^a   Mehandru, Saurabh ^a   Velinzon, Klara ^a   Jung, In Hyuk ^c   Yoo, Ji Young ^c   Oh, Goo Taeg ^c   Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Hanyang University   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD11B ANTIGEN; CD135 ANTIGEN; CD14 ANTIGEN; COLONY STIMULATING FACTOR 1; GLYCOPROTEIN P 15095; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BARE LYMPHOCYTE SYNDROME; CONTROLLED STUDY; DENDRITIC CELL; INTIMA; LIPID BLOOD LEVEL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; AORTA; ATHEROSCLEROSIS; DENDRITIC CELLS; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION REGULATION; LEUKOCYTE REDUCTION PROCEDURES; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; SIGNAL TRANSDUCTION;

EID: 81955161809     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.09.014     Document Type: Article

References (65)

1. Ait-Oufella H., Salomon B.L., Potteaux S., Robertson A.K., Gourdy P., Zoll J., Merval R., Esposito B., Cohen J.L., Fisson S., et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 2006, 12:178-180.
2. Annacker O., Coombes J.L., Malmstrom V., Uhlig H.H., Bourne T., Johansson-Lindbom B., Agace W.W., Parker C.M., Powrie F. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 2005, 202:1051-1061.
3. Benagiano M., D'Elios M.M., Amedei A., Azzurri A., van der Zee R., Ciervo A., Rombolà G., Romagnani S., Cassone A., Del Prete G. Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J. Immunol. 2005, 174:6509-6517.
4. Cheong C., Idoyaga J., Do Y., Pack M., Park S.H., Lee H., Kang Y.S., Choi J.H., Kim J.Y., Bonito A., et al. Production of monoclonal antibodies that recognize the extracellular domain of mouse langerin/CD207. J. Immunol. Methods 2007, 324:48-62.
5. Cheong C., Matos I., Choi J.-H., Dandamudi D.B., Shrestha E., Longhi M.P., Jeffrey K.L., Anthony R.M., Kluger C., Nchinda G., et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 2010, 143:416-429.
6. Cheong C., Matos I., Choi J.H., Schauer J.D., Dandamudi D.B., Shrestha E., Makeyeva J.A., Li X., Li P., Steinman R.M., Park C.G. New monoclonal anti-mouse DC-SIGN antibodies reactive with acetone-fixed cells. J. Immunol. Methods 2010, 360:66-75.
7. Chitu V., Stanley E.R. Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol. 2006, 18:39-48.
8. Cho H.J., Shashkin P., Gleissner C.A., Dunson D., Jain N., Lee J.K., Miller Y., Ley K. Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol. Genomics 2007, 29:149-160.
9. Choi J.H., Do Y., Cheong C., Koh H., Boscardin S.B., Oh Y.S., Bozzacco L., Trumpfheller C., Park C.G., Steinman R.M. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J. Exp. Med. 2009, 206:497-505.
10. Coombes J.L., Siddiqui K.R., Arancibia-Cárcamo C.V., Hall J., Sun C.M., Belkaid Y., Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007, 204:1757-1764.
11. Cybulsky M.I., Jongstra-Bilen J. Resident intimal dendritic cells and the initiation of atherosclerosis. Curr. Opin. Lipidol. 2010, 21:397-403.
12. Darrasse-Jèze G., Deroubaix S., Mouquet H., Victora G.D., Eisenreich T., Yao K.H., Masilamani R.F., Dustin M.L., Rudensky A., Liu K., Nussenzweig M.C. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 2009, 206:1853-1862.
13. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., Wu S., Lang R., Iredale J.P. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 2005, 115:56-65.
14. Edelson B.T., Kc W., Juang R., Kohyama M., Benoit L.A., Klekotka P.A., Moon C., Albring J.C., Ise W., Michael D.G., et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 2010, 207:823-836.
15. Galkina E., Kadl A., Sanders J., Varughese D., Sarembock I.J., Ley K. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 2006, 203:1273-1282.
16. Gautier E.L., Huby T., Saint-Charles F., Ouzilleau B., Pirault J., Deswaerte V., Ginhoux F., Miller E.R., Witztum J.L., Chapman M.J., Lesnik P. Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis. Circulation 2009, 119:2367-2375.
17. + DCs. J. Exp. Med. 2009, 206:3115-3130.
18. Gown A.M., Tsukada T., Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol. 1986, 125:191-207.
19. Habets K.L., van Puijvelde G.H., van Duivenvoorde L.M., van Wanrooij E.J., de Vos P., Tervaert J.W., van Berkel T.J., Toes R.E., Kuiper J. Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. Cardiovasc. Res. 2010, 85:622-630.
20. Hansson G.K., Jonasson L. The discovery of cellular immunity in the atherosclerotic plaque. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1714-1717.
21. Hansson G.K., Libby P. The immune response in atherosclerosis: A double-edged sword. Nat. Rev. Immunol. 2006, 6:508-519.
22. Hansson G.K., Holm J., Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 1989, 135:169-175.
23. Hansson G.K., Libby P., Schönbeck U., Yan Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 2002, 91:281-291.
24. Hermansson A., Johansson D.K., Ketelhuth D.F., Andersson J., Zhou X., Hansson G.K. Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation 2011, 123:1083-1091.
25. Jeon H.J., Choi J.H., Jung I.H., Park J.G., Lee M.R., Lee M.N., Kim B., Yoo J.Y., Jeong S.J., Kim D.Y., et al. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation 2010, 121:1124-1133.
26. Johansson-Lindbom B., Svensson M., Pabst O., Palmqvist C., Marquez G., Förster R., Agace W.W. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 2005, 202:1063-1073.
27. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G.K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986, 6:131-138.
28. Jongstra-Bilen J., Haidari M., Zhu S.N., Chen M., Guha D., Cybulsky M.I. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 2006, 203:2073-2083.
29. Kissenpfennig A., Henri S., Dubois B., Laplace-Builhé C., Perrin P., Romani N., Tripp C.H., Douillard P., Leserman L., Kaiserlian D., et al. Dynamics and function of Langerhans cells in vivo: Dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005, 22:643-654.
30. Kuivaniemi H., Platsoucas C.D., Tilson M.D. Aortic aneurysms: An immune disease with a strong genetic component. Circulation 2008, 117:242-252.
31. Lessner S.M., Prado H.L., Waller E.K., Galis Z.S. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am. J. Pathol. 2002, 160:2145-2155.
32. Liu P., Yu Y.R., Spencer J.A., Johnson A.E., Vallanat C.T., Fong A.M., Patterson C., Patel D.D. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler. Thromb. Vasc. Biol. 2008, 28:243-250.
33. Liu K., Victora G.D., Schwickert T.A., Guermonprez P., Meredith M.M., Yao K., Chu F.F., Randolph G.J., Rudensky A.Y., Nussenzweig M.C. In vivo analysis of dendritic cell development and homeostasis. Science 2009, 324:392-397.
34. Mallat Z., Gojova A., Brun V., Esposito B., Fournier N., Cottrez F., Tedgui A., Groux H. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003, 108:1232-1237.
35. Matthews W., Jordan C.T., Wiegand G.W., Pardoll D., Lemischka I.R. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 1991, 65:1143-1152.
36. Merad M., Manz M.G. Dendritic cell homeostasis. Blood 2009, 113:3418-3427.
37. Mor A., Planer D., Luboshits G., Afek A., Metzger S., Chajek-Shaul T., Keren G., George J. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007, 27:893-900.
38. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., Shortman K. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 2006, 7:663-671.
39. Ohnmacht C., Pullner A., King S.B., Drexler I., Meier S., Brocker T., Voehringer D. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 2009, 206:549-559.
40. Onai N., Obata-Onai A., Tussiwand R., Lanzavecchia A., Manz M.G. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. J. Exp. Med. 2006, 203:227-238.
41. Paulson K.E., Zhu S.N., Chen M., Nurmohamed S., Jongstra-Bilen J., Cybulsky M.I. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ. Res. 2010, 106:383-390.
42. Rajavashisth T., Qiao J.H., Tripathi S., Tripathi J., Mishra N., Hua M., Wang X.P., Loussararian A., Clinton S., Libby P., Lusis A. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. J. Clin. Invest. 1998, 101:2702-2710.
43. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994, 180:83-93.
44. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
45. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994, 179:1109-1118.
46. Sasaki N., Yamashita T., Takeda M., Shinohara M., Nakajima K., Tawa H., Usui T., Hirata K. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation 2009, 120:1996-2005.
47. Siddiqui K.R., Laffont S., Powrie F. E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis. Immunity 2010, 32:557-567.
48. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J. Exp. Med. 1974, 139:380-397.
49. Steinman R.M., Witmer M.D. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA 1978, 75:5132-5136.
50. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., Hansson G.K. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 1995, 92:3893-3897.
51. Stoneman V., Braganza D., Figg N., Mercer J., Lang R., Goddard M., Bennett M. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ. Res. 2007, 100:884-893.
52. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007, 204:1775-1785.
53. Sun J., Sukhova G.K., Wolters P.J., Yang M., Kitamoto S., Libby P., MacFarlane L.A., Mallen-St Clair J., Shi G.P. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat. Med. 2007, 13:719-724.
54. Sun J., Hartvigsen K., Chou M.Y., Zhang Y., Sukhova G.K., Zhang J., Lopez-Ilasaca M., Diehl C.J., Yakov N., Harats D., et al. Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation 2010, 122:808-820.
55. Sung S.S., Fu S.M., Rose C.E., Gaskin F., Ju S.T., Beaty S.R. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 2006, 176:2161-2172.
56. Takeda M., Yamashita T., Sasaki N., Nakajima K., Kita T., Shinohara M., Ishida T., Hirata K. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler. Thromb. Vasc. Biol. 2010, 30:2495-2503.
57. Van Voorhis W.C., Valinsky J., Hoffman E., Luban J., Hair L.S., Steinman R.M. Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication. J. Exp. Med. 1983, 158:174-191.
58. Waskow C., Liu K., Darrasse-Jèze G., Guermonprez P., Ginhoux F., Merad M., Shengelia T., Yao K., Nussenzweig M. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 2008, 9:676-683.
59. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models. Nat. Rev. Immunol. 2008, 8:802-815.
60. Weber C., Meiler S., Döring Y., Koch M., Drechsler M., Megens R.T., Rowinska Z., Bidzhekov K., Fecher C., Ribechini E., et al. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J. Clin. Invest. 2011, 121:2898-2910.
61. Weyand C.M., Ma-Krupa W., Goronzy J.J. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun. Rev. 2004, 3:46-53.
62. Whitman S.C., Rateri D.L., Szilvassy S.J., Yokoyama W., Daugherty A. Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1049-1054.
63. Witmer-Pack M.D., Hughes D.A., Schuler G., Lawson L., McWilliam A., Inaba K., Steinman R.M., Gordon S. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J. Cell Sci. 1993, 104:1021-1029.
64. Woollard K.J., Geissmann F. Monocytes in atherosclerosis: Subsets and functions. Nat Rev Cardiol 2010, 7:77-86.
65. +) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102:2919-2922.